Abstract
Inhibition of the androgen receptor leads to regression of normal and malignant prostate tissue. The authors discuss therapeutic strategies for directly targeting the androgen receptor to help address the problem of castrate‐resistant prostate cancer. Copyright © 2013 John Wiley & Sons
Cite
CITATION STYLE
APA
Lamb, A. D., & Neal, D. E. (2013). Role of the androgen receptor in prostate cancer. Trends in Urology & Men’s Health, 4(3), 26–30. https://doi.org/10.1002/tre.331
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free